Italia markets closed

Novozymes A/S (NVZMF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
50,850,00 (0,00%)
Alla chiusura: 10:24AM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente50,85
Aperto50,85
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno50,85 - 50,85
Intervallo di 52 settimane38,16 - 70,50
Volume200
Media Volume2.356
Capitalizzazione14,182B
Beta (5 anni mensile)N/D
Rapporto PE (ttm)26,21
EPS (ttm)1,94
Prossima data utiliN/D
Rendimento e dividendo (forward)0,82 (1,60%)
Data ex dividendo17 mar 2022
Stima target 1AN/D
  • GlobeNewswire

    Novozymes delivers historically strong full-year results

    Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, 2026. In the 2022 financial year, Novozymes delivers 9% organic sales growth – 11% organic sales growth in the fourth quarter alone – an EBIT-margin before special items[*] of 26.4%, and ROIC including goodwill before

  • GlobeNewswire

    Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner

    Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large. COPENHAGEN, Denmark – December 12, 2022. The proposed combination of Novozymes A/S ("Novozymes") and Chr. Hansen Holding A/S ("Chr. Hansen") will create a strong biosolutions group wi

  • GlobeNewswire

    As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiative

    Novozymes has renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its supply chain by 35%. By 2050, Novozymes will reach net-zero. COPENHAGEN, Denmark – November 10, 2022. Novozymes’ first science-based targets were approved in 2019. Today Novozymes has new, SBTi approved near and long-term science-based emission reduction targets and is one of the first companies in the world to have committed to S